---
title: "Cobenfy (xanomeline and trospium chloride) in schizophrenia: Access and coverage questions"
description: "Access and coverage questions on Cobenfy (xanomeline and trospium chloride) in schizophrenia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Access and support, Cost and coverage, and Patient support. Questions: What are the NDC codes for COBENFY? Is there COBENFY copay assistance? Is COBENFY covered by Medicare and Medicaid? How much does COBENFY cost patients out of pocket? 2 further questions follow. 6 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/cobenfy--schizophrenia/access-and-coverage"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Cobenfy (xanomeline and trospium chloride) in schizophrenia: Access and coverage questions

Manufacturer: Bristol-Myers Squibb Company  
Prescribing information: [Cobenfy](https://packageinserts.bms.com/pi/pi_cobenfy.pdf)

## Access and billing

<a id="cobenfy-ndc"></a>

### What are the NDC codes for COBENFY?

> “COBENFY capsules are packaged as described in Table 5.
> Table 5:	
> COBENFY Packaging Configurations
> Capsule 
> Strength
> Total 
> Package 
> Count
> Package 
> Configuration
> Package 
> Components
> NDC Code
> 50 mg/20 mg
> 60
> Bottle
> N/A
> 0003-0050-60
> 100
> Hospital 
> Unit-Dose Blister
> 10 Blister Cards with 
> 10 Capsules Each
> 0003-0050-98
> 100 mg/20 mg
> 60
> Bottle
> N/A
> 0003-1100-60
> 100
> Hospital 
> Unit-Dose Blister
> 10 Blister Cards with 
> 10 Capsules Each
> 0003-1100-98
> 125 mg/30 mg
> 60
> Bottle
> N/A
> 0003-0125-60
> 100
> Hospital 
> Unit-Dose Blister
> 10 Blister Cards with 
> 10 Capsules Each
> 0003-0125-98
> 50 mg/20 mg (4) 
> 100 mg/20 mg (52)
> 56
> Starter Pack for 
> 100 mg/20 mg dose
> 1 Mixed Blister Wallet:  
> four (4)  
> 50 mg/20 mg capsules 
> and ten (10) 
> 100 mg/20 mg capsules 
> and 
> 3 Wallets: fourteen (14) 
> 100 mg/20 mg capsules  
> in each wallet
> 0003-5200-56”

Source: [COBENFY: Prescribing information, page 7, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_cobenfy.pdf#page=7)

## Access and support

<a id="cobenfy-copay-coverage"></a>

### Is there COBENFY copay assistance?

> “COBENFY Co-Pay Assistance Program*
>
> Patients with commercial insurance may be eligible to pay as little as $0 per month.
>
> *	Eligibility and Terms and Conditions apply. See the COBENFY Co-Pay Assistance Program terms and conditions for details.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=COBENFY%20Co%2DPay%20Assistance%20Program%2A,terms%20and%20conditions%20for%20details.)

> ““Commercially Insured Patients” is inclusive of commercially insured patients eligible and receiving assistance through the Co-Pay Assistance Program. “Medicare and Medicaid Patients” are not eligible for the Co-Pay Assistance Program, but may be eligible for other forms of third-party co-pay assistance.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=%E2%80%9CCommercially%20Insured%20Patients%E2%80%9D%20is%20inclusive,forms%20of%20third%2Dparty%20co%2Dpay%20assistance.)

<a id="cobenfy-access-liaison"></a>

### What COBENFY access support is available for prescribers?

> “Our team of Patient Access Liaisons (PALs) are local and dedicated professionals who can support you with navigating your patient’s access to COBENFY.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=Our%20team%20of%20Patient%20Access,your%20patient%E2%80%99s%20access%20to%20COBENFY.)

> “Prior authorization support is available when COBENFY is prescribed.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=Prior%20authorization%20support%20is%20available%20when%20COBENFY%20is%20prescribed.)

## Cost and coverage

<a id="cobenfy-medicare-medicaid-coverage"></a>

### Is COBENFY covered by Medicare and Medicaid?

> “99% of Medicare and Medicaid patients are COVERED for COBENFY*”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=99%25%20of%20Medicare%20and%20Medicaid%20patients%20are%20COVERED%20for%20COBENFY%2A)

> “*	Formulary data are provided by Fingertip Formulary Data and are current as of 04/26. Because formularies change and many payers offer more than one formulary, please check directly with the payer to confirm coverage requirements and status for individual patients. Coverage and benefits are subject to change without notice. The accurate completion of reimbursement or cover-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item. Bristol Myers Squibb does not endorse any individual health plans.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=Formulary%20data%20are%20provided%20by,endorse%20any%20individual%20health%20plans.)

<a id="cobenfy-out-of-pocket-cost"></a>

### How much does COBENFY cost patients out of pocket?

> “9 out of 10 patients paid $0 out of pocket for COBENFY<sup>†</sup>”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=9%20out%20of%2010%20patients%20paid%20%240%20out%20of%20pocket%20for)

> “<sup>†</sup>	Out-of-pocket distribution data cost averages are provided by IQVIA FIA and include prescriptions filled among Commercial, Medicare, and Medicaid patients, latest 4 weeks ending 12/26/25, and reflect any financial assistance that was used. “Commercially Insured Patients” is inclusive of commercially insured patients eligible and receiving assistance through the Co-Pay Assistance Program. “Medicare and Medicaid Patients” are not eligible for the Co-Pay Assistance Program, but may be eligible for other forms of third-party co-pay assistance. Some patients may pay more than the cost listed above.”

Source: [COBENFY: Prescription Coverage Finder, captured 2026-11-08](https://www.cobenfyhcp.com/support#:~:text=Out%2Dof%2Dpocket%20distribution%20data%20cost%20averages,than%20the%20cost%20listed%20above.)

## Patient support

<a id="cobenfy-cares-patient-support"></a>

### Is there a COBENFY patient support program?

> “COBENFY Cares connects enrolled patients and care partners to free, personalized support via live conversations with COBENFY Cares Champions—available 24/7, 365 days a year.”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=COBENFY%20Cares%20connects%20enrolled%20patients,24%2F7%2C%20365%20days%20a%20year.)

> “Offers dedicated, free, live, 1-on-1 weekly support with a COBENFY Cares Champion* for patients and their loved ones
> 	Assists with navigating financial conversations and co-pay support (for eligible patients)<sup>†</sup>
> 	Connects patients and loved ones to trusted local housing, transportation, and community support resources<sup>‡</sup>
> 	Guides treatment support, including expectation setting for dosing/AEs, appointment prep, and adherence follow-up”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=Offers%20dedicated%2C%20free%2C%20live%2C%201%2Don%2D1,appointment%20prep%2C%20and%20adherence%20follow%2Dup)

> “Help patients enroll in 24/7 support to start and stay on treatment at COBENFYCares.com or by calling 1-877-COBENFY (1-877-262-3639).”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=Help%20patients%20enroll%20in%2024%2F7,or%20by%20calling%201%2D877%2DCOBENFY%20%281%2D877%2D262%2D3639%29.)

> “*	COBENFY Cares Champions are available to provide support to patients who have been prescribed COBENFY. Champions do not provide medical advice or care. COBENFY Cares Champions are provided as a service by Bristol Myers Squibb. Patients should discuss any questions about their medical conditions and treatment options with their healthcare providers.”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=COBENFY%20Cares%20Champions%20are%20available,options%20with%20their%20healthcare%20providers.)

> “<sup>†</sup>	See full Terms and Conditions at www.COBENFY.com/co-pay-assistance-program.”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=See%20full%20Terms%20and%20Conditions%20at%20www.COBENFY.com%2Fco%2Dpay%2Dassistance%2Dprogram.)

> “<sup>‡</sup>	These are independent services not operated by Bristol Myers Squibb. COBENFY Cares cannot guarantee services, eligibility, or approvals. Availability may vary by location.”

Source: [COBENFY: COBENFY™ (xanomeline and trospium chloride) Patient Support | For HCPs, captured 2026-11-13](https://www.cobenfyhcp.com/support/patient-support#:~:text=These%20are%20independent%20services%20not,Availability%20may%20vary%20by%20location.)

Note: The last three passages are footnotes: * applies to the COBENFY Cares Champions, † to the co-pay support bullet, and ‡ to the bullet on local housing, transportation, and community support resources.

## Related pages
- [Medical information: Cobenfy (xanomeline and trospium chloride): Schizophrenia](https://www.evicenter.com/medical-information/cobenfy--schizophrenia)
- [Indication](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/storage-and-supply)
